|
|
||||||||

,§
*
Division of Immunobiology, Research Institute for Biological Sciences, Science University of Tokyo, Noda City, Chiba, Japan;
Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba, Japan;
Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan;
§
CREST, Japan Science and Technology Corporation, Tokyo, Japan; and
¶
Cadus Pharmaceutical Corp., Tarrytown, NY 10591
The development of Th1 and Th2 cells is determined by the type of
antigenic stimulation involved in the initial cell activation step.
Evidence indicates that costimulatory signals, such as those delivered
by CD28, play an important role in Th2 development, but little is known
about how CD28 costimulation contributes to Th2 development. In this
study, TCR cross-linking was insufficient for Th2 development, while
the addition of CD28 costimulation drastically increased Th2 generation
through the IL-4-mediated pathway. Th2 generation following CD28
costimulation was not simply explained by the enhancement of IL-4
production in naive T cells. To generate Th2 cells after TCR
cross-linking only, it was necessary to add a 20- to 200-fold excess of
IL-4 generated after TCR and CD28 stimulation. TCR cross-linking
increased the expression level and binding property of the IL-4R, but
enhanced the sensitivity to IL-4 only slightly. In contrast, as
evidenced by the enhanced phosphorylation of Jak3, the IL-4R
-chain,
and STAT6 following IL-4 stimulation, CD28 costimulation increased
IL-4R sensitivity without affecting its expression and binding
property. This evidence of the enhancement of IL-4R sensitivity
increases our understanding of how CD28 costimulation accelerates Th2
development.
This article has been cited by other articles:
![]() |
A. Serra, S. Nuti, S. Tavarini, C. Sammicheli, D. Rosa, G. Saletti, E. Soldaini, S. Abrignani, and A. Wack Coligation of the Hepatitis C Virus Receptor CD81 with CD28 Primes Naive T Lymphocytes to Acquire Type 2 Effector Function J. Immunol., July 1, 2008; 181(1): 174 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sehra, D. Patel, S. Kusam, Z.-Y. Wang, C.-H. Chang, and A. L. Dent A Role for Caspases in Controlling IL-4 Expression in T Cells J. Immunol., March 15, 2005; 174(6): 3440 - 3446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Jenks, B. J. Eisfelder, and J. Miller LFA-1 co-stimulation inhibits Th2 differentiation by down-modulating IL-4 responsiveness Int. Immunol., March 1, 2005; 17(3): 315 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watanabe, S. Watanabe, Y. Hara, Y. Harada, M. Kubo, K. Tanabe, H. Toma, and R. Abe ICOS-Mediated Costimulation on Th2 Differentiation Is Achieved by the Enhancement of IL-4 Receptor-Mediated Signaling J. Immunol., February 15, 2005; 174(4): 1989 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kimura, H. Hosokawa, M. Yamashita, A. Hasegawa, C. Iwamura, H. Watarai, M. Taniguchi, T. Takagi, S. Ishii, and T. Nakayama Regulation of T helper type 2 cell differentiation by murine Schnurri-2 J. Exp. Med., February 7, 2005; 201(3): 397 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bian, S.-i. Hiraoka, M. Tomura, X.-Y. Zhou, Y. Yashiro-Ohtani, Y. Mori, J. Shimizu, S. Ono, K. Dunussi-Joannopoulos, S. Wolf, et al. The capacity of the natural ligands for CD28 to drive IL-4 expression in naive and antigen-primed CD4+ and CD8+ T cells Int. Immunol., January 1, 2005; 17(1): 73 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Garcia, M. Martin, and S. M. Michalek Role of B7 Costimulatory Molecules in Mediating Systemic and Mucosal Antibody Responses to Attenuated Salmonella enterica Serovar Typhimurium and Its Cloned Antigen Infect. Immun., October 1, 2004; 72(10): 5824 - 5831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inami, M. Yamashita, Y. Tenda, A. Hasegawa, M. Kimura, K. Hashimoto, N. Seki, M. Taniguchi, and T. Nakayama CD28 Costimulation Controls Histone Hyperacetylation of the Interleukin 5 Gene Locus in Developing Th2 Cells J. Biol. Chem., May 28, 2004; 279(22): 23123 - 23133. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seki, M. Miyazaki, W. Suzuki, K. Hayashi, K. Arima, E. Myburgh, K. Izuhara, F. Brombacher, and M. Kubo IL-4-Induced GATA-3 Expression Is a Time-Restricted Instruction Switch for Th2 Cell Differentiation J. Immunol., May 15, 2004; 172(10): 6158 - 6166. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tokoyoda, K. Tsujikawa, H. Matsushita, Y. Ono, T. Hayashi, Y. Harada, R. Abe, M. Kubo, and H. Yamamoto Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells Int. Immunol., May 1, 2004; 16(5): 643 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Jung, J. E. Foley, A. A. Erdmann, M. A. Eckhaus, and D. H. Fowler CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects Blood, November 1, 2003; 102(9): 3439 - 3446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gu, A. K. Tolin, J. Jain, H. Huang, L. Santiago, and B. S. Mitchell Targeted Disruption of the Inosine 5'-Monophosphate Dehydrogenase Type I Gene in Mice Mol. Cell. Biol., September 15, 2003; 23(18): 6702 - 6712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mora, L. M. Stephenson, B. Enerson, J. Youn, A. D. Keegan, and M. Boothby New Programming of IL-4 Receptor Signal Transduction in Activated T Cells: Stat6 Induction and Th2 Differentiation Mediated by IL-4R{alpha} Lacking Cytoplasmic Tyrosines J. Immunol., August 15, 2003; 171(4): 1891 - 1900. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Komine, K. Hayashi, W. Natsume, T. Watanabe, Y. Seki, N. Seki, R. Yagi, W. Sukzuki, H. Tamauchi, K. Hozumi, et al. The Runx1 Transcription Factor Inhibits the Differentiation of Naive CD4+ T Cells into the Th2 Lineage by Repressing GATA3 Expression J. Exp. Med., July 7, 2003; 198(1): 51 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rigby, T. Rouse, and E. H. Field Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells Blood, March 1, 2003; 101(5): 2024 - 2032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsumoto, Y.-i. Seki, R. Watanabe, K. Hayashi, J. A. Johnston, Y. Harada, R. Abe, A. Yoshimura, and M. Kubo A Role of Suppressor of Cytokine Signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated Interleukin 2 Production J. Exp. Med., February 17, 2003; 197(4): 425 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-i. Seki, K. Hayashi, A. Matsumoto, N. Seki, J. Tsukada, J. Ransom, T. Naka, T. Kishimoto, A. Yoshimura, and M. Kubo Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation PNAS, October 1, 2002; 99(20): 13003 - 13008. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arima, H. Toyama, H. Ichii, S. Kojima, S. Okada, M. Hatano, G. Cheng, M. Kubo, T. Fukuda, and T. Tokuhisa A Putative Silencer Element in the IL-5 Gene Recognized by Bcl6 J. Immunol., July 15, 2002; 169(2): 829 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haspot, F. Villemain, G. Laflamme, F. Coulon, D. Olive, J. Tiollier, J.-P. Soulillou, and B. Vanhove Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses Blood, March 15, 2002; 99(6): 2228 - 2234. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yagi, H. Nagai, Y. Iigo, T. Akimoto, T. Arai, and M. Kubo Development of Atopic Dermatitis-Like Skin Lesions in STAT6-Deficient NC/Nga Mice J. Immunol., February 15, 2002; 168(4): 2020 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Atamas, I. G. Luzina, H. Dai, S. G. Wilt, and B. White Synergy Between CD40 Ligation and IL-4 on Fibroblast Proliferation Involves IL-4 Receptor Signaling J. Immunol., February 1, 2002; 168(3): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yagi, W. Suzuki, N. Seki, M. Kohyama, T. Inoue, T. Arai, and M. Kubo The IL-4 production capability of different strains of naive CD4+ T cells controls the direction of the Th cell response Int. Immunol., January 1, 2002; 14(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-h. Ogawa, G. Nagamatsu, M. Watanabe, S. Watanabe, T. Hayashi, S. Horita, K. Nitta, H. Nihei, K. Tezuka, and R. Abe Opposing Effects of Anti-Activation-Inducible Lymphocyte- Immunomodulatory Molecule/Inducible Costimulator Antibody on the Development of Acute Versus Chronic Graft-Versus-Host Disease J. Immunol., November 15, 2001; 167(10): 5741 - 5748. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Padigel, P. J. Perrin, and J. P. Farrell The Development of a Th1-Type Response and Resistance to Leishmania major Infection in the Absence of CD40-CD40L Costimulation J. Immunol., November 15, 2001; 167(10): 5874 - 5879. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tamura, O. Igarashi, A. Hino, H. Yamane, S. Aizawa, T. Kato, and H. Nariuchi Impairment in the Expression and Activity of Fyn During Differentiation of Naive CD4+ T Cells into the Th2 Subset J. Immunol., August 15, 2001; 167(4): 1962 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Martin, G. Hajishengallis, D. J. Metzger, S. M. Michalek, T. D. Connell, and M. W. Russell Recombinant Antigen-Enterotoxin A2/B Chimeric Mucosal Immunogens Differentially Enhance Antibody Responses and B7-Dependent Costimulation of CD4+ T Cells Infect. Immun., January 1, 2001; 69(1): 252 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tanaka, C. E. Demeure, M. Rubio, G. Delespesse, and M. Sarfati Human Monocyte-derived Dendritic Cells Induce Naive T Cell Differentiation into T Helper Cell Type 2 (Th2) or Th1/Th2 Effectors: Role of Stimulator/Responder Ratio J. Exp. Med., August 8, 2000; 192(3): 405 - 412. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |